Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US (Q79474065)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2007

Language	Label	Description	Also known as
English	Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US	scientific article published on 01 January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

type 2 diabetes

1 reference

based on heuristic

inferred from title

insulin therapy

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

author name string

Ray JA

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Valentine WJ

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Roze S

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Nicklasson L

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Cobden D

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Raskin P

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Garber A

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Palmer AJ

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

103-113

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Validation of the CORE Diabetes Model against epidemiological and clinical studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Lipid levels and the use of lipid-lowering agents in England and Scotland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Spotlight on insulin aspart in type 1 and 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Insulin initiation in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2006.00581.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79474065&oldid=1873243816"